CA2652968C - Polymer mixtures of anionic and cationic polysaccharides and use thereof - Google Patents

Polymer mixtures of anionic and cationic polysaccharides and use thereof Download PDF

Info

Publication number
CA2652968C
CA2652968C CA2652968A CA2652968A CA2652968C CA 2652968 C CA2652968 C CA 2652968C CA 2652968 A CA2652968 A CA 2652968A CA 2652968 A CA2652968 A CA 2652968A CA 2652968 C CA2652968 C CA 2652968C
Authority
CA
Canada
Prior art keywords
compositions according
chitosan
polysaccharide
polysaccharide compositions
polysaccharides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2652968A
Other languages
English (en)
French (fr)
Other versions
CA2652968A1 (en
Inventor
Sergio Paoletti
Ivan Donati
Eleonora Marsich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universita degli Studi di Trieste
Original Assignee
Universita degli Studi di Trieste
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universita degli Studi di Trieste filed Critical Universita degli Studi di Trieste
Publication of CA2652968A1 publication Critical patent/CA2652968A1/en
Application granted granted Critical
Publication of CA2652968C publication Critical patent/CA2652968C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08—Cellulose derivatives
    • C08L1/26—Cellulose ethers
    • C08L1/28—Alkyl ethers
    • C08L1/286—Alkyl ethers substituted with acid radicals, e.g. carboxymethyl cellulose [CMC]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/04—Alginic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/06—Pectin; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/10—Heparin; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/12—Agar or agar-agar, i.e. mixture of agarose and agaropectin; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CA2652968A 2006-05-22 2007-05-21 Polymer mixtures of anionic and cationic polysaccharides and use thereof Active CA2652968C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000202A ITPD20060202A1 (it) 2006-05-22 2006-05-22 Miscele polimeriche di polisaccaridi anionici e cationici e loro impiego
ITPD2006A000202 2006-05-22
PCT/EP2007/054860 WO2007135116A1 (en) 2006-05-22 2007-05-21 Polymer mixtures of anionic and cationic polysaccharides and use thereof

Publications (2)

Publication Number Publication Date
CA2652968A1 CA2652968A1 (en) 2007-11-29
CA2652968C true CA2652968C (en) 2014-08-05

Family

ID=38529755

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2652968A Active CA2652968C (en) 2006-05-22 2007-05-21 Polymer mixtures of anionic and cationic polysaccharides and use thereof

Country Status (10)

Country Link
US (1) US8951991B2 (https=)
EP (1) EP2021408B1 (https=)
JP (1) JP2009537597A (https=)
CN (1) CN101454392A (https=)
AT (1) ATE479453T1 (https=)
BR (1) BRPI0711620A2 (https=)
CA (1) CA2652968C (https=)
DE (1) DE602007008879D1 (https=)
IT (1) ITPD20060202A1 (https=)
WO (1) WO2007135116A1 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1391669B1 (it) * 2008-07-23 2012-01-17 Universita' Degli Studi Di Trieste Materiali nanocompositi formati da una matrice polisaccaridica e nanoparticelle metalliche, loro preparazione ed uso
IT1391668B1 (it) * 2008-07-23 2012-01-17 Universita' Degli Studi Di Trieste Materiali nanocompositi basati su nanoparticelle metalliche stabilizzate con polisaccaridi a struttura ramificata.
IT1404145B1 (it) * 2010-12-27 2013-11-15 Altergon Sa Composizioni di acido ialuronico stabilizzate verso l'azione di degradazione del calore o degli enzimi
CN103084079B (zh) * 2013-02-04 2015-08-05 浙江大学 可原位水分散聚电解质络合物渗透汽化膜的制备方法
CN105903087A (zh) * 2015-12-14 2016-08-31 上海其胜生物制剂有限公司 一种兼具内聚性和弥散性的粘弹剂的制备方法
ITUA20164153A1 (it) 2016-06-07 2017-12-07 Jointherapeutics S R L Composizioni polisaccaridiche impiegabili nella riparazione tissutale
IT201600075246A1 (it) * 2016-07-19 2018-01-19 Jointherapeutics S R L Composizioni comprendenti una matrice polisaccaridica per il rilascio controllato di principi attivi.
IT201600130342A1 (it) * 2016-12-22 2018-06-22 Biopolife S R L Addotti solubili di acido borico o suoi derivati e precursori con derivati oligosaccaridici del chitosano
IT201700060530A1 (it) * 2017-06-01 2018-12-01 Jointherapeutics S R L Derivati polisaccaridici idrosolubili, loro procedimento di preparazione e loro usi
CN111065423B (zh) 2017-08-22 2022-04-12 莫比斯医疗有限公司 用于关节润滑的脂质体制剂
IT201700111939A1 (it) * 2017-10-05 2019-04-05 Jointherapeutics S R L Composizione farmaceutica per l’uso nel trattamento di stati infiammatori
IT201900006250A1 (it) 2019-04-23 2020-10-23 Fidia Farm Spa Medicazione per il trattamento della cute lesa
CN108918495B (zh) * 2018-08-21 2020-10-09 辽宁大学 基于2-醛基罗丹明类衍生物的分光光度法定量检测氰根离子的方法
EP3733755A1 (en) 2019-04-30 2020-11-04 Universita Degli Studi di Trieste Homogeneous hydrogels from chitosan oligosaccharide derivatives and applications thereof
CN110075360B (zh) * 2019-05-21 2021-12-07 福建吉特瑞生物科技有限公司 一种壳聚糖/ha基个性化颅、颌面、脊椎骨修复材料及其制备方法
IT201900010740A1 (it) * 2019-07-02 2021-01-02 Medacta Int Sa Biocompatible compositions comprising a biocompatible thickening polymer and a chitosan derivative
CN112920369B (zh) * 2021-01-28 2022-07-26 孝感市易生新材料有限公司 自抗菌性乳酸基水性聚氨酯、其制备方法及其乳液
CN117295786A (zh) * 2021-05-14 2023-12-26 优瑞株式会社 聚合物组合物及其制备方法
CN114306725B (zh) * 2021-11-30 2022-10-04 南方科技大学 一种单面粘合水凝胶粘合剂及其制备方法、应用
CN114632445B (zh) * 2022-02-25 2023-04-28 湖南益安生物科技有限公司 一种复合医用生物高分子材料及其制备方法
CN114793769A (zh) * 2022-05-06 2022-07-29 四川省通惠田源集团有限公司 一种牧草种植方法
CN115212349B (zh) * 2022-07-05 2023-11-21 浦易(上海)生物技术股份有限公司 可凝胶化的组合物及其制备方法和应用
EP4522178A1 (en) 2023-01-19 2025-03-19 Moebius Medical Ltd. A long-acting liposomal composition for treatment of pain in articular disorders
CN117126306A (zh) * 2023-09-25 2023-11-28 江苏恒辉安防股份有限公司 一种生物质防老剂以及浅色导电手套及其制备方法
CN118078854A (zh) * 2024-03-14 2024-05-28 华南理工大学 一种聚电解质仿生滑液复合物及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409904A (en) * 1984-11-13 1995-04-25 Alcon Laboratories, Inc. Hyaluronic acid compositions and methods
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
EP0820305A2 (en) * 1995-04-04 1998-01-28 Wound Healing of Oklahoma Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant
US5972326A (en) * 1995-04-18 1999-10-26 Galin; Miles A. Controlled release of pharmaceuticals in the anterior chamber of the eye
US6277792B1 (en) * 1998-12-28 2001-08-21 Venture Innovations, Inc. Viscosified aqueous fluids and viscosifier therefor
KR20020014189A (ko) * 2000-08-16 2002-02-25 윤광심 키토산-알긴산를 이용한 화상상처 치료제 개발
US6756363B1 (en) * 2000-11-17 2004-06-29 Wound Healing Of Oklahoma, Inc. Solutions and films of glycated chitosan

Also Published As

Publication number Publication date
ATE479453T1 (de) 2010-09-15
WO2007135116A1 (en) 2007-11-29
CA2652968A1 (en) 2007-11-29
BRPI0711620A2 (pt) 2017-05-09
EP2021408A1 (en) 2009-02-11
JP2009537597A (ja) 2009-10-29
US20090197832A1 (en) 2009-08-06
EP2021408B1 (en) 2010-09-01
CN101454392A (zh) 2009-06-10
US8951991B2 (en) 2015-02-10
ITPD20060202A1 (it) 2007-11-23
DE602007008879D1 (de) 2010-10-14

Similar Documents

Publication Publication Date Title
CA2652968C (en) Polymer mixtures of anionic and cationic polysaccharides and use thereof
Rinaudo Main properties and current applications of some polysaccharides as biomaterials
US7651702B2 (en) Crosslinking hyaluronan and chitosanic polymers
Dulong et al. Amphiphilic and thermosensitive copolymers based on pullulan and Jeffamine®: Synthesis, characterization and physicochemical properties
US20080188585A1 (en) Photocrosslinked-polysaccharide composition and production process of the same
ZA200103800B (en) Cross-linking process of carboxylated polysaccharides.
RS62488B1 (sr) Unakrsno povezani hijaluronat male molekulske težine, otporan na razgradnju
US7879818B2 (en) Hyaluronic acid-based cross-linked nanoparticles
P Fuenzalida et al. Polysaccharide-protein nanoassemblies: novel soft materials for biomedical and biotechnological applications
JP2025156408A (ja) 多糖誘導体、多糖誘導体－薬物コンジュゲート、その製造方法
WO2013037965A2 (en) Ionic gel
Fernández-Solís et al. Synthesis, characterization and stability of crosslinked chitosan-maltodextrin pH-sensitive nanogels
M. Martínez et al. The role of anionic polysaccharides in the preparation of nanomedicines with anticancer applications
EP1951761B1 (en) New derivatives of hyaluronic acid, their preparation process and their uses
JP2018521169A (ja) 光除去可能な保護基を使用する多糖類の架橋方法
Wang A novel hydrogel crosslinked hyaluronan with glycol chitosan
EP3313893B1 (en) Derivatives of sulfated polysaccharides, method of preparation, modification and use thereof
CN114727912B (zh) 交联透明质酸丁酸酯或丁酸酯-甲酸酯衍生物及其交联方法
JP2006291097A (ja) ヒアルロン酸誘導体、およびその製造法
KR20260009267A (ko) 변형된 가교된 중합체
Todaro et al. Xyloglucan self-assembled nanostructures and gels for biomedical applications

Legal Events

Date Code Title Description
EEER Examination request
H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-H100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE AND LATE FEE NOT PAID BY DEADLINE OF NOTICE

Effective date: 20251106

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251110

H11 Ip right ceased following rejected request for revival

Free format text: ST27 STATUS EVENT CODE: T-6-6-H10-H11-H101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TIME LIMIT FOR REVERSAL EXPIRED

Effective date: 20251121

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-6-6-H10-H13-H100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE AND LATE FEE NOT PAID BY DEADLINE OF NOTICE

Effective date: 20260223

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260225